NeuroPPEye

We are working to develop new technologies that combine a new type of camera system, referred to as hyperspectral, with Artificial Intelligence (AI) systems to reveal to neurosurgeons information that is otherwise not visible to the naked eye during surgery. Two studies are currently bringing this “hyperspectral” technology to operating theatres. The NeuroHSI study uses a hyperspectral camera attached to an external scope to show surgeons critical information on tissue blood flow and distinguishes vulnerable structures which need to be protected. The NeuroPPEye study is developing this technology adapted for surgical microscopes, to guide tumour surgery.

• Focus: Translational research in biomedical optics for hyperspectral imaging based quantitative fluorescence linked with an in-patient neurosurgery clinical study
• Line manager: Tom Vercauteren
• Clinical collaborator: King’s College Hospital
• Industry collaborator: Hypervision Surgical
• Salary: Grade 6, £38,826 - £45,649 per annum, including London Weighting Allowance

We are actively involving patients and carers to make our research on next generation neurosurgery more relevant and impactful. Early February 2022, our research scientists from King’s College London and King’s College Hospital organised a Patient and Public Involvement (PPI) meeting with support from The Brain Tumour Charity.